Supplementary Figure 3 from Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with Rapamycin
Year: 2023
Type: supplementary-materials
Abstract: PDF - 421KB, Schematic illustrating the mechanism of synergy for BI 836845 and rapamycin.
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362621296
